SPY331.87+1.81 0.55%
DIA271.40+2.99 1.11%
IXIC10,987.37+46.20 0.42%

Satsuma Pharmaceuticals Q3 EPS $(2.26) Down From $(1.48) YoY

Satsuma Pharmaceuticals (NASDAQ:STSA) reported quarterly losses of $(2.26) per share. This is a 52.7 percent decrease over losses of $(1.48) per share from the same period last year.

Benzinga · -

Satsuma Pharmaceuticals (NASDAQ:STSA) reported quarterly losses of $(2.26) per share. This is a 52.7 percent decrease over losses of $(1.48) per share from the same period last year.